Joan Ellis

Joan Ellis

Dickinson Wright

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Intellectual Property Legal News: Volume 2, Number 1

TEVA PHARMACEUTICALS: IS IT TIME TO RETHINK HOW YOU WILL ARGUE CLAIM CONSTRUCTION? The United States Supreme Court decided in Teva Pharmaceuticals USA Inc. v. Sandoz Inc. that the Federal Circuit must review all...more

3/31/2015 - Claim Construction Clear Error Standard De Novo Standard of Review Extrinsic Evidence Indefiniteness Nautilus Inc. v. Biosig Instruments Patent Infringement Patents SCOTUS Standard of Review Teva Pharmaceuticals Teva v Sandoz

Health Care Legal News - August 7, 2013 • Volume 3, Number 2

In This Issue: - IRS ISSUES TRANSITION RELIEF ON THE ONE-YEAR DELAY IN ACA’S INFORMATION REPORTING AND EMPLOYER SHARED RESPONSIBILITY RULES: On July 9, 2013, the IRS issued Notice 2013-45 which provides...more

8/7/2013 - Affordable Care Act Delays Employer Mandates Healthcare IRS Pay or Play Reporting Requirements Shared Responsibility Rule Transition Relief

Intellectual Property Legal News -The Supreme Court Holds Human Genes Are Unpatentable

In a unanimous decision written by Justice Thomas, the Supreme Court held that naturally-occurring DNA sequences are unpatentable. The Court has long held that certain subject matter is not patent eligible under 35 USC § 101....more

7/30/2013 - DNA Myriad Patent-Eligible Subject Matter Patents SCOTUS

Intellectual Property LEGAL NEWS - March 22, 2013 • Volume 1, Number 2

In This Issue: - AMERICA INVENTS ACT FINAL IMPLEMENTATION: FROM FIRST-TO-INVENT TO FIRST-TO-FILE: The America Invents Act (“AIA”), which went into effect September 16, 2011, introduces some of the most...more

3/25/2013 - America Invents Act Apple DNA First-to-File First-to-Invent Human Genes Patent Applications Patent Reform Patent-Eligible Subject Matter Patents Retailers SCOTUS Trademarks USPTO

4 Results
|
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×